Guess what year this ScienceDaily headline appeared:
“New SARS-Like Virus Can Jump Directly from Bats to Humans, No Treatment Available.”
If you guessed 2020, you’re wrong. The article was published in 2015. The source was the University of North Carolina at Chapel Hill.
That’s where scientist Ralph Baric, Ph.D, and a team that included Baric’s Wuhan Institute of Virology (WIV) colleague, Shi Zhengli, used genetic engineering and synthetic biology to create a “new bat SARS-like virus . . . that can jump directly from its bat hosts to humans.”
The two are scientists whose work involves collecting samples of the nearly 5,000 coronaviruses in bat populations and manipulating them for the sole purpose of making them more infectious to humans.
Ostensibly, the research Baric and Zhengli conduct is intended to help scientists get ahead of any coronavirus that might have the potential to emerge as a human pathogen.
The reality is this: There is little evidence that this research has prepared us to meet the challenges of the current COVID-19 pandemic. In fact, there are suspicions that the research may have caused the virus.
There’s also ample evidence that Baric has strong ties to Big Pharma—thanks to laws that allow researchers at publicly funded universities to commercialize their research.